OLEMA PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
OLEMA PHARMACEUTICALS, INC. (OLMA) had Shares Outstanding (Cover Page) of 87.50 million shares as of 2026-08-06, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-06: Entity Common Stock, Shares Outstanding 87.50M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 87.35M shares.
- 2026-03-11: Entity Common Stock, Shares Outstanding 87.16M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 68.66M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 87.50M shares 10-Q · filed 2026-08-10 |
| 2026-05-07 | 87.35M shares 10-Q · filed 2026-05-12 |
| 2026-03-11 | 87.16M shares 10-K · filed 2026-03-16 |
| 2025-11-06 | 68.66M shares 10-Q · filed 2025-11-10 |
| 2025-08-07 | 68.63M shares 10-Q · filed 2025-08-11 |
| 2025-05-08 | 68.42M shares 10-Q · filed 2025-05-13 |
| 2025-03-13 | 68.33M shares 10-K · filed 2025-03-18 |
| 2024-11-08 | 57.30M shares 10-Q · filed 2024-11-12 |
| 2024-08-02 | 57.27M shares 10-Q · filed 2024-08-06 |
| 2024-05-03 | 55.93M shares 10-Q · filed 2024-05-08 |
| 2024-03-07 | 55.91M shares 10-K · filed 2024-03-11 |
| 2023-11-03 | 54.77M shares 10-Q · filed 2023-11-07 |
| 2023-08-04 | 41.35M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 40.76M shares 10-Q · filed 2023-05-09 |
| 2023-03-03 | 40.63M shares 10-K · filed 2023-03-09 |
| 2022-11-04 | 40.46M shares 10-Q · filed 2022-11-08 |
| 2022-08-05 | 40.42M shares 10-Q · filed 2022-08-09 |
| 2022-05-04 | 40.35M shares 10-Q · filed 2022-05-09 |
| 2022-02-23 | 40.35M shares 10-K · filed 2022-02-28 |
| 2021-11-05 | 40.29M shares 10-Q · filed 2021-11-10 |
| 2021-08-06 | 39.56M shares 10-Q · filed 2021-08-10 |
| 2021-05-07 | 40.17M shares 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |